Physician profile
Stephen Jones
NPI 1346555455
$202,047.04
in general payments reported to CMS, 2019-2025
12 companies · $84K in 2025
The $84K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $130 · 2021: $415 · 2022: $22K · 2023: $35K · 2024: $61K · 2025: $84K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $178K · Food and Beverage: $1,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $177,869.20 |
| Food and Beverage | $1,558.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kedplasma LLC | $199,350.40 | 2022-2025 | |
| Horizon Therapeutics Plc | $779.45 | 2021-2023 | Tepezza |
| Abbvie INC. | $740.20 | 2022-2025 | |
| Alcon Vision LLC | $512.29 | 2020-2025 | Clareon, Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $142.35 | 2019-2020 | |
| Amgen INC. | $137.36 | 2024-2025 | Tepezza |
| Microsurgical Technology, INC. | $112.44 | 2024 | |
| Glaukos Corporation | $102.00 | 2019-2021 | |
| Boston Scientific Corporation | $66.67 | 2020 | |
| Allergan, INC. | $64.19 | 2021-2022 | |
| Genentech USA, INC. | $21.99 | 2024 | Vabysmo |
| Dompe US, INC. | $17.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.